Marina Aleksandrovna Gusareva
Marina Aleksandrovna Gusareva has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Oleg Ivanovich Kit
National Medical Research Centre for Oncology, Rostov-on-Don, Russia
8 shared publications - N. G. Kosheleva
National Medical Research Centre for Oncology
7 shared publications - Natalya V. Soldatkina
National Medical Research Centre for Oncology
7 shared publications - O. K. Bondarenko
National Medical Research Centre for Oncology
7 shared publications - Yuriy A. Gevorkyan
National Medical Research Centre for Oncology
7 shared publications - Dmitry A. Savchenko
National Medical Research Centre for Oncology
6 shared publications
Latest Publications
- Open Access
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 49-66
Morphological characteristics of An3Ca endometrioid carcinoma and visceral organs in female nude mice with experimental diabetes mellitus
Purpose of the study . To investigate the morphological features of induced An3Ca endometrioid carcinoma and visceral organs in BALB/c nude mice under conditions of diabetes mellitus. Materials and methods . Female BALB/c nude mice weighing 25 ± 2.5 g were used to model uterine tumor growth under conditions of diabetes mellitus. The animals were divided into two experimental groups: group 1 (control) – intrauterine growth of endometrioid carcinoma (n = 5); group 2 (study group) – intrauterine growth of endometrioid carcinoma in the presence of diabetes mellitus (n = 5). Sections of the tumor nodules and organs (uterus, ovaries, liver, lungs, thyroid gland, adrenal glands, and pancreas) were examined microscopically, with images captured using a digital camera. Results . Tumor growth without alloxan administration resulted in the formation of a single tumor nodule in the right uterine horn, with preservation of the main morphological features of its architecture. In contrast, alloxan administration was associated with the formation of a tumor consisting of several separate nodules that completely obliterated the structure of the right ovary and replaced it with tumor tissue. Metastatic involvement of the liver accompanied by vascular congestion of the parenchyma was observed. In the lungs, destruction of the alveolar and bronchial structures was accompanied by vascular congestion, foci of hemorrhage, mucus accumulation in the airway lumens, and the presence of tumor cells. Marked thickening of the colloid was observed throughout the thyroid follicles. Involutional changes were noted in the X-zone and zona glomerulosa of the adrenal cortex, with focal expansion of the zona fasciculata. Diabetes modeling resulted in almost complete loss of the exocrine pancreatic parenchyma, exposing the stromal framework of the organ. Its morphological identity could be established only from isolated small areas of degeneratively altered acini and rare remnants of the islets of Langerhans. Conclusion . In the experimental bimodal model combining two pathological processes, cancer and diabetes mellitus, morphological evidence of mutually reinforcing mechanisms of adverse systemic effects involving multiple organs was observed. This pronounced synergistic effect was manifested by stimulation of tumor progression and pathological changes in visceral organs, expanding our understanding of cancer pathogenesis in the presence of comorbid disease.
- 20 September 2026
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 13 (3) , 49-66
Open AccessMorphological characteristics of An3Ca endometrioid carcinoma and visceral organs in female nude mice with experimental diabetes mellitus
Purpose of the study . To investigate the morphological features of induced An3Ca endometrioid carcinoma and visceral organs in BALB/c nude mice under conditions of diabetes mellitus. Materials and methods . Female BALB/c nude mice weighing 25 ± 2.5 g were used to model uterine tumor growth under conditions of diabetes mellitus. The animals were divided into two experimental groups: group 1 (control) – intrauterine growth of endometrioid carcinoma (n = 5); group 2 (study group) – intrauterine growth of endometrioid carcinoma in the presence of diabetes mellitus (n = 5). Sections of the tumor nodules and organs (uterus, ovaries, liver, lungs, thyroid gland, adrenal glands, and pancreas) were examined microscopically, with images captured using a digital camera. Results . Tumor growth without alloxan administration resulted in the formation of a single tumor nodule in the right uterine horn, with preservation of the main morphological features of its architecture. In contrast, alloxan administration was associated with the formation of a tumor consisting of several separate nodules that completely obliterated the structure of the right ovary and replaced it with tumor tissue. Metastatic involvement of the liver accompanied by vascular congestion of the parenchyma was observed. In the lungs, destruction of the alveolar and bronchial structures was accompanied by vascular congestion, foci of hemorrhage, mucus accumulation in the airway lumens, and the presence of tumor cells. Marked thickening of the colloid was observed throughout the thyroid follicles. Involutional changes were noted in the X-zone and zona glomerulosa of the adrenal cortex, with focal expansion of the zona fasciculata. Diabetes modeling resulted in almost complete loss of the exocrine pancreatic parenchyma, exposing the stromal framework of the organ. Its morphological identity could be established only from isolated small areas of degeneratively altered acini and rare remnants of the islets of Langerhans. Conclusion . In the experimental bimodal model combining two pathological processes, cancer and diabetes mellitus, morphological evidence of mutually reinforcing mechanisms of adverse systemic effects involving multiple organs was observed. This pronounced synergistic effect was manifested by stimulation of tumor progression and pathological changes in visceral organs, expanding our understanding of cancer pathogenesis in the presence of comorbid disease.
- Open Access
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 34-48
Impact of combined treatment for rectal cancer on long-term outcomes
Purpose of the study . To analyze the effectiveness of combined treatment for rectal cancer and evaluate the impact of ileostomy closure timing on treatment outcomes. Patients and methods. A study of treatment outcomes in 250 patients with locally advanced rectal cancer was conducted to assess the influence of patient age, sex, tumor characteristics, and timing of ileostomy closure. From January 2020 to November 2025, patients underwent treatment and follow-up including radiotherapy with a total focal dose of 50–54 Gy combined with capecitabine- based radiosensitization, followed by low anterior resection of the rectum with preventive ileostomy formation. Results . A significant prognostic factor has been established – metastatic involvement of regional lymph nodes (pN2), which increases the risk of death by 3.6 times (p = 0.0001) and the risk of disease progression by 4.1 times (p = 0.0004). Factors such as patients' age, gender, distance from the lower edge of the tumor, the degree of differentiation, and tumor invasion into the colon wall did not show a significant impact on overall survival and progression-free survival rates, which may be due to the limitations of the study (recruitment of a homogeneous group of patients with uniform treatment). No significant differences were found in overall survival rates (p = 0.9573) and progression-free survival rates (p = 0.5278) between groups of patients with ileostomy closure within 2 months and more than 4 months after low anterior resection of the rectum. Closure of the ileostomy within 2 months was accompanied by a decrease in the total number of postoperative complications (p < 0.001), parastomal hernias (p = 0.004), elevated creatinine levels (p = 0.037), the incidence of diversion colitis (p < 0.001), and diarrhea (p = 0.001). Conclusion . The study confirmed the safety of the approach to closing the ileostomy within 2 months after radical surgery before the start of adjuvant chemotherapy in the combined treatment of rectal cancer. Early closure of the ileostomy is recommended in patients without involvement of regional lymph nodes (pN0) or with involvement of regional lymph nodes (pN1) in the absence of clinical and radiological signs of colorectal anastomosis insufficiency.
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 34-48
Open AccessImpact of combined treatment for rectal cancer on long-term outcomes
Purpose of the study . To analyze the effectiveness of combined treatment for rectal cancer and evaluate the impact of ileostomy closure timing on treatment outcomes. Patients and methods. A study of treatment outcomes in 250 patients with locally advanced rectal cancer was conducted to assess the influence of patient age, sex, tumor characteristics, and timing of ileostomy closure. From January 2020 to November 2025, patients underwent treatment and follow-up including radiotherapy with a total focal dose of 50–54 Gy combined with capecitabine- based radiosensitization, followed by low anterior resection of the rectum with preventive ileostomy formation. Results . A significant prognostic factor has been established – metastatic involvement of regional lymph nodes (pN2), which increases the risk of death by 3.6 times (p = 0.0001) and the risk of disease progression by 4.1 times (p = 0.0004). Factors such as patients' age, gender, distance from the lower edge of the tumor, the degree of differentiation, and tumor invasion into the colon wall did not show a significant impact on overall survival and progression-free survival rates, which may be due to the limitations of the study (recruitment of a homogeneous group of patients with uniform treatment). No significant differences were found in overall survival rates (p = 0.9573) and progression-free survival rates (p = 0.5278) between groups of patients with ileostomy closure within 2 months and more than 4 months after low anterior resection of the rectum. Closure of the ileostomy within 2 months was accompanied by a decrease in the total number of postoperative complications (p < 0.001), parastomal hernias (p = 0.004), elevated creatinine levels (p = 0.037), the incidence of diversion colitis (p < 0.001), and diarrhea (p = 0.001). Conclusion . The study confirmed the safety of the approach to closing the ileostomy within 2 months after radical surgery before the start of adjuvant chemotherapy in the combined treatment of rectal cancer. Early closure of the ileostomy is recommended in patients without involvement of regional lymph nodes (pN0) or with involvement of regional lymph nodes (pN1) in the absence of clinical and radiological signs of colorectal anastomosis insufficiency.
- Open Access
- 13 March 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (1) , 52-62
Genotyping and viral load dynamics in residual tumor tissue after chemoradiation therapy for HPV-positive anal cancer
Генотипирование и динамика вирусной нагрузки в ткани остаточной опухоли после химиолучевой терапии ВПЧ-позитивного анального рака
- 13 March 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (1) , 52-62
Open AccessGenotyping and viral load dynamics in residual tumor tissue after chemoradiation therapy for HPV-positive anal cancer
Генотипирование и динамика вирусной нагрузки в ткани остаточной опухоли после химиолучевой терапии ВПЧ-позитивного анального рака
- Open Access
- 16 August 2025
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 24 (3) , 106-114
The effect of the timing of the elimination of preventive ileostomy on the incidence of severe low anterior resection syndrome
AIM: to study the effect of early ileostomy closure on the incidence of low anterior resection syndrome (LARS) in patients with rectal cancer.PATIENTS AND METHODS: one-hundred patients with rectal cancer underwent radiation therapy with a total focal dose of 50-54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The primary endpoint of the study was the incidence of significant anorectal dysfunction at 3 months after ileostomy closure. Secondary endpoints included the incidence and severity of clinical manifestations of anorectal dysfunction, anal incontinence score according to the Wexner scale, overall distribution of anorectal dysfunction (absent, mild, severe) and the incidence of postoperative complications. Patients were randomized into two groups: with early ileostomy closure within 6 (5; 7) weeks after low anterior rectal resection (50 patients) and with late ileostomy closure after 24.5 (20; 29) weeks (50 patients). Three months after ileostomy closure, a questionnaire was done using the LARS and Wexner scales.RESULTS OF THE STUDY: the results obtained at 3 months after ileostomy closure showed advantages of the early ileostomy closure group. According to the GIFO scale, clinical manifestations of anorectal dysfunction were significantly less common in this group (p < 0.05). According to the LARS scale, the incidence of anorectal dysfunction in the early ileostomy closure group was 40%, while in the late closure group it was 70% (OR (odds ratio) = 3.50; 95% CI (confidence interval): 1.49–8.23; p = 0.0046). Moreover, severe LARS was detected in 6% and 26% of patients, respectively (OR = 0.12; 95% CI: 0.03–0.43; p = 0.012). The Wexner scale score was also significantly better in the early closure group (5 (4; 8) points) compared to the late closure group (9 (8; 10) points, p < 0.0001). With regard to the complications that developed in the late ileostomy closure group, a significantly higher incidence of colitis was noted (21/50 (42%) versus 6/50 (12%) cases, p = 0.0014).CONCLUSION: in the course of the conducted work it was established that 3 months after ileostomy closure, patients in the early closure group showed less manifestations of anorectal dysfunction compared to patients in the late closure group.
- 16 August 2025
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 24 (3) , 106-114
Open AccessThe effect of the timing of the elimination of preventive ileostomy on the incidence of severe low anterior resection syndrome
AIM: to study the effect of early ileostomy closure on the incidence of low anterior resection syndrome (LARS) in patients with rectal cancer.PATIENTS AND METHODS: one-hundred patients with rectal cancer underwent radiation therapy with a total focal dose of 50-54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The primary endpoint of the study was the incidence of significant anorectal dysfunction at 3 months after ileostomy closure. Secondary endpoints included the incidence and severity of clinical manifestations of anorectal dysfunction, anal incontinence score according to the Wexner scale, overall distribution of anorectal dysfunction (absent, mild, severe) and the incidence of postoperative complications. Patients were randomized into two groups: with early ileostomy closure within 6 (5; 7) weeks after low anterior rectal resection (50 patients) and with late ileostomy closure after 24.5 (20; 29) weeks (50 patients). Three months after ileostomy closure, a questionnaire was done using the LARS and Wexner scales.RESULTS OF THE STUDY: the results obtained at 3 months after ileostomy closure showed advantages of the early ileostomy closure group. According to the GIFO scale, clinical manifestations of anorectal dysfunction were significantly less common in this group (p < 0.05). According to the LARS scale, the incidence of anorectal dysfunction in the early ileostomy closure group was 40%, while in the late closure group it was 70% (OR (odds ratio) = 3.50; 95% CI (confidence interval): 1.49–8.23; p = 0.0046). Moreover, severe LARS was detected in 6% and 26% of patients, respectively (OR = 0.12; 95% CI: 0.03–0.43; p = 0.012). The Wexner scale score was also significantly better in the early closure group (5 (4; 8) points) compared to the late closure group (9 (8; 10) points, p < 0.0001). With regard to the complications that developed in the late ileostomy closure group, a significantly higher incidence of colitis was noted (21/50 (42%) versus 6/50 (12%) cases, p = 0.0014).CONCLUSION: in the course of the conducted work it was established that 3 months after ileostomy closure, patients in the early closure group showed less manifestations of anorectal dysfunction compared to patients in the late closure group.
- 31 March 2025
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
THE IMPACT OF HYPERTHYROIDISM ON PARATHYROID HORMONE CONTENT IN MALIGNANT GROWTH
Hyperthyroidism is caused by increased synthesis and secretion of thyroid hormones. It increases the risk of some malignant neoplasms. The thyroid gland and parathyroid glands have a common embryological origin. Parathyroid hormone (PTH) is secreted by the cells of the parathyroid glands. The aim of the study was to determine the level of parathyroid hormone in the blood serum, tumor, skin and thyroid/parathyroid gland complex in C57BL/6 mice of both sexes with Lewis lung carcinoma and induced hyperthyroidism. Materials and Methods. C57BL/6 mice of both sexes (n=112) were used in the trial. The animals were divided into experimental groups: intact group (n=16); control group (n=32) – mice with induced hyperthyroidism; comparison group (n=32) – mice with subcutaneous inoculation of Lewis lung carcinoma (LLC); main group (n=32) – mice with subcutaneous inoculation of LLC and induced hyperthyroidism. The PTH content in blood serum, skin, tumor and organ complex “thyroid gland/parathyroid glands” was determined using ELISA kits (XEMA, Russia). Results. The LLC growth in animals with hyperthyroidism was accompanied by PTH increase in the blood serum of animals of both sexes: in females it was 1.5 times higher compared to that in the intact group and the group with isolated LLC, and 1.4 times higher compared to that in the group of animals with hyperthyroidism only, in males it was 2.6 and 1.6 times higher compared to that in the intact group and the group with hyperthyroidism respectively. In the skin of females of the main group, the PTH level exceeded the intact values by 9 times, in males – by 2.8 times. In the skin of animals with a combined pathology (LLC and hyperthyroidism), PTH concentration in females was 6 times higher, and in males 4 times higher compared to mice with isolated LLC. The combination of LLC and hyperthyroidism also affected the organ complex “thyroid gland/parathyroid glands”: PTH level exceeded intact values by 1.7 times in females, by 3.6 times in males, and the corresponding values in the group of mice with LLC by 1.5 and 5.8 times, respectively.
- 31 March 2025
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
THE IMPACT OF HYPERTHYROIDISM ON PARATHYROID HORMONE CONTENT IN MALIGNANT GROWTH
Hyperthyroidism is caused by increased synthesis and secretion of thyroid hormones. It increases the risk of some malignant neoplasms. The thyroid gland and parathyroid glands have a common embryological origin. Parathyroid hormone (PTH) is secreted by the cells of the parathyroid glands. The aim of the study was to determine the level of parathyroid hormone in the blood serum, tumor, skin and thyroid/parathyroid gland complex in C57BL/6 mice of both sexes with Lewis lung carcinoma and induced hyperthyroidism. Materials and Methods. C57BL/6 mice of both sexes (n=112) were used in the trial. The animals were divided into experimental groups: intact group (n=16); control group (n=32) – mice with induced hyperthyroidism; comparison group (n=32) – mice with subcutaneous inoculation of Lewis lung carcinoma (LLC); main group (n=32) – mice with subcutaneous inoculation of LLC and induced hyperthyroidism. The PTH content in blood serum, skin, tumor and organ complex “thyroid gland/parathyroid glands” was determined using ELISA kits (XEMA, Russia). Results. The LLC growth in animals with hyperthyroidism was accompanied by PTH increase in the blood serum of animals of both sexes: in females it was 1.5 times higher compared to that in the intact group and the group with isolated LLC, and 1.4 times higher compared to that in the group of animals with hyperthyroidism only, in males it was 2.6 and 1.6 times higher compared to that in the intact group and the group with hyperthyroidism respectively. In the skin of females of the main group, the PTH level exceeded the intact values by 9 times, in males – by 2.8 times. In the skin of animals with a combined pathology (LLC and hyperthyroidism), PTH concentration in females was 6 times higher, and in males 4 times higher compared to mice with isolated LLC. The combination of LLC and hyperthyroidism also affected the organ complex “thyroid gland/parathyroid glands”: PTH level exceeded intact values by 1.7 times in females, by 3.6 times in males, and the corresponding values in the group of mice with LLC by 1.5 and 5.8 times, respectively.
- Open Access
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 6-13
Intravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer
Purpose of the study. Assessment of clinical safety and effectiveness of radium‑223 in patients with bone metastases from castration-resistant prostate cancer.Patients and methods. The study involved materials on 15 patients with bone metastases from castration-resistant prostate cancer aged 58–81 years, with the mean age of 67.2 ± 6.5 years, who were examined and received full treatment with 6 intravenous injections of radium‑223 chloride [223Ra] at the National Medical Research Centre for Oncology. Most patients (73.3 %) showed ECOG 1 performance status. Pain syndrome before the treatment was registered in 12 (80 %) patients.Results. Evaluation of the tolerability of radium chloride did not show hematological reactions such as anemia and thrombocytopenia. One patient had grade II intestinal toxicity after the 3rd injection managed with medication. Assessment of indirect signs of the treatment effectiveness demonstrated that 6 people showed an increase in PSA during treatment, while alkaline phosphatase levels were within normal range indicating no bone destruction. 8 of 12 patients with pain syndrome showed its relief during the therapy. The following results were obtained during a follow-up examination after 3 months in 15 patients who received the full treatment course: stabilization in 8 patients; improvement in 4 patients with decreased metabolic activity and lower numbers of metastatic foci; progression with the appearance of new metastatic foci in the bones in 3 patients.Conclusion. Radium chloride showed good results in the treatment of patients with bone metastases from castration-resistant prostate cancer. Low toxicity and improvement in the quality of life by pain relief make this treatment technique promising.
- 13 November 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (4) , 6-13
Open AccessIntravenous radionuclide therapy with radium chloride [223Ra] in patients with bone metastases from castration-resistant prostate cancer
Purpose of the study. Assessment of clinical safety and effectiveness of radium‑223 in patients with bone metastases from castration-resistant prostate cancer.Patients and methods. The study involved materials on 15 patients with bone metastases from castration-resistant prostate cancer aged 58–81 years, with the mean age of 67.2 ± 6.5 years, who were examined and received full treatment with 6 intravenous injections of radium‑223 chloride [223Ra] at the National Medical Research Centre for Oncology. Most patients (73.3 %) showed ECOG 1 performance status. Pain syndrome before the treatment was registered in 12 (80 %) patients.Results. Evaluation of the tolerability of radium chloride did not show hematological reactions such as anemia and thrombocytopenia. One patient had grade II intestinal toxicity after the 3rd injection managed with medication. Assessment of indirect signs of the treatment effectiveness demonstrated that 6 people showed an increase in PSA during treatment, while alkaline phosphatase levels were within normal range indicating no bone destruction. 8 of 12 patients with pain syndrome showed its relief during the therapy. The following results were obtained during a follow-up examination after 3 months in 15 patients who received the full treatment course: stabilization in 8 patients; improvement in 4 patients with decreased metabolic activity and lower numbers of metastatic foci; progression with the appearance of new metastatic foci in the bones in 3 patients.Conclusion. Radium chloride showed good results in the treatment of patients with bone metastases from castration-resistant prostate cancer. Low toxicity and improvement in the quality of life by pain relief make this treatment technique promising.
- Open Access
- 12 November 2024
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 23 (4) , 40-47
Prediction of anorectal dysfunction in the combined treatment of rectal cancer
AIM: to assess the risk of severe low anterior resection syndrome (LARS) in patients with rectal cancer after combined treatment.PATIENTS AND METHODS: from July 2022 to November 2023, 50 patients with rectal cancer underwent radiation with a total focal dose of 50–54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The ileostomy was closed after 4 months. Prior to and after radiation, the anorectal function was assessed using high-resolution anorectal manometry (HRAM) and the LARS scale.RESULTS: the most significant predicting factors for severe LARS were maximal contraction pressure and first sensation volume. Three months after ileostomy closure, the patients were divided into groups depending on the HRAM parameters. Group 1: nine patients with severe LARS (34 points on the LARS scale), with a decrease in maximal contraction pressure by ≥ 30% and an increased first sensation volume by ≥ 60%, according to HRAM. Group 2: four patients out of 36 had severe LARS (31 points on the LARS scale), with a decrease in maximal contraction pressure by 5–29% and an increased first sensation volume by 10–59%, according to HRAM. Group 3: in 5 patients with a decreased maximal contraction pressure by ≤ 4% and an increased volume of the first sensation by ≤ 9%, LARS did not develop.CONCLUSION: a decrease in the maximal contraction pressure by 30% or more and an increase in the volume of the first sensation by 60% or more after radiation therapy can increase the risk of severe LARS. This group of patients requires prevention and correction of anorectal dysfunction.
- 12 November 2024
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 23 (4) , 40-47
Open AccessPrediction of anorectal dysfunction in the combined treatment of rectal cancer
AIM: to assess the risk of severe low anterior resection syndrome (LARS) in patients with rectal cancer after combined treatment.PATIENTS AND METHODS: from July 2022 to November 2023, 50 patients with rectal cancer underwent radiation with a total focal dose of 50–54 Gy with radiomodification with capecitabine and low anterior rectal resection with preventive ileostomy. The ileostomy was closed after 4 months. Prior to and after radiation, the anorectal function was assessed using high-resolution anorectal manometry (HRAM) and the LARS scale.RESULTS: the most significant predicting factors for severe LARS were maximal contraction pressure and first sensation volume. Three months after ileostomy closure, the patients were divided into groups depending on the HRAM parameters. Group 1: nine patients with severe LARS (34 points on the LARS scale), with a decrease in maximal contraction pressure by ≥ 30% and an increased first sensation volume by ≥ 60%, according to HRAM. Group 2: four patients out of 36 had severe LARS (31 points on the LARS scale), with a decrease in maximal contraction pressure by 5–29% and an increased first sensation volume by 10–59%, according to HRAM. Group 3: in 5 patients with a decreased maximal contraction pressure by ≤ 4% and an increased volume of the first sensation by ≤ 9%, LARS did not develop.CONCLUSION: a decrease in the maximal contraction pressure by 30% or more and an increase in the volume of the first sensation by 60% or more after radiation therapy can increase the risk of severe LARS. This group of patients requires prevention and correction of anorectal dysfunction.
- Open Access
- 2 October 2024
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 39 (3) , 156-163
Changes in electrical parameters of the heart in an experimental model of malignant tumor growth during of hyperthyroidism
Experimental and clinical studies demonstrate the possibility of modulating the development of malignant tumors in thyroid imbalance, in particular hyperthyroidism, which negatively affects the electrophysiology of the heart. In an experimental model of tumor growth during of hyperthyroidism, activation of the tumor was shown.Aim: To study electrophysiological parameters of the mouse heart at the initial stages of transplantable tumor growth during of hyperthyroidism.Material and Methods. In female mice of the C57BL/6 line (n = 20) was created a model of melanoma B16/F10 growth during of hyperthyroidism, which was induced by daily intraperitoneal administration of liothyronine sodium (T3) for a long time and confirmed by determining the content of thyroid-stimulating hormone and triiodothyronine in the blood using the radioimmune method. On the 5th day of T3 administration, the melanoma was transplanted. ECG was recorded non-invasively (ecgTUN- NEL, ecgAVG software, emka TECHNOLOGIES, France) on the 1st and 3rd days of T3 administration, in groups with a tumor – on the 6th day after its transplantation.Results. Pathological changes were revealed: in the group with hyperthyroidism – rhythm irregularity, decrease the amplitude of P and T below the isoline, widening of the QRS, on the 3rd day – the death of 1 mouse was noted due to large-focal myocardial infarction; in the group with melanoma – only sinus arrhythmia and decreased heart rate; in the group with a combination of pathologies – an almost normal ECG, with the exception of an increase in P amplitude and a slight increase in QRS.Conclusion. Already in the early stages of hyperthyroidism or tumor growth, there was a violation of myocardial depolarization/ repolarization processes, capable of causing even death of the animal. In case of comorbidity, the majority of ECG parameters normalized, indicating the inclusion of compensatory mechanisms in the interaction of pathologies. The results demonstrate the need for a deeper study of the mechanisms of interaction of several simultaneously existing pathologies in the body.
- 2 October 2024
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 39 (3) , 156-163
Open AccessChanges in electrical parameters of the heart in an experimental model of malignant tumor growth during of hyperthyroidism
Experimental and clinical studies demonstrate the possibility of modulating the development of malignant tumors in thyroid imbalance, in particular hyperthyroidism, which negatively affects the electrophysiology of the heart. In an experimental model of tumor growth during of hyperthyroidism, activation of the tumor was shown.Aim: To study electrophysiological parameters of the mouse heart at the initial stages of transplantable tumor growth during of hyperthyroidism.Material and Methods. In female mice of the C57BL/6 line (n = 20) was created a model of melanoma B16/F10 growth during of hyperthyroidism, which was induced by daily intraperitoneal administration of liothyronine sodium (T3) for a long time and confirmed by determining the content of thyroid-stimulating hormone and triiodothyronine in the blood using the radioimmune method. On the 5th day of T3 administration, the melanoma was transplanted. ECG was recorded non-invasively (ecgTUN- NEL, ecgAVG software, emka TECHNOLOGIES, France) on the 1st and 3rd days of T3 administration, in groups with a tumor – on the 6th day after its transplantation.Results. Pathological changes were revealed: in the group with hyperthyroidism – rhythm irregularity, decrease the amplitude of P and T below the isoline, widening of the QRS, on the 3rd day – the death of 1 mouse was noted due to large-focal myocardial infarction; in the group with melanoma – only sinus arrhythmia and decreased heart rate; in the group with a combination of pathologies – an almost normal ECG, with the exception of an increase in P amplitude and a slight increase in QRS.Conclusion. Already in the early stages of hyperthyroidism or tumor growth, there was a violation of myocardial depolarization/ repolarization processes, capable of causing even death of the animal. In case of comorbidity, the majority of ECG parameters normalized, indicating the inclusion of compensatory mechanisms in the interaction of pathologies. The results demonstrate the need for a deeper study of the mechanisms of interaction of several simultaneously existing pathologies in the body.
- Open Access
- 15 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 38-53
Features of the functioning of the hypothalamic-pituitary-thyroid axis in mice with Lewis carcinoma on the background of induced hyperthyroidism
Thyroid hormones (TH) influence the processes of cell proliferation and differentiation, but their role in the processes of carcinogenesis is contradictory. The purpose of the study. To study the effect of induced hyperthyroidism in mice of both sexes with intertwined Lewis carcinoma (LLC) on the activity of the hypothalamic-pituitary-thyroid axis (GGT). Materials and methods. The experimental model was mixed-sex mice of the C57BL/6 line with subcutaneously transplanted LLC on the background of induced hyperthyroidism (main group). Two control groups were used: control group I – mice with sodium liothyronine- induced hyperthyroidism and control group II – mice with subcutaneously transplanted LLC. On the 25th day after tumor transplantation, the level of thyrotropin- releasing hormone (TRH), thyroid- stimulating hormone (TSH), triiodothyronine (T3), total and free thyroxine (T4, FT4) was determined in the homogenates of GGT organs and in blood serum. Results. In female mice, hyperthyroidism caused an increase in the level of TRH in the hypothalamus and a decrease in TSH in the pituitary gland; in males, a decrease in TRH only in the hypothalamus. In control group II, euthyroid disorder syndrome developed: In mice of both sexes, serum levels of T4 and FT4 were found to decrease against the background of unchanged T3 levels and an increase in TSH content only in females. In the females of the main group, an increase in the level of TSH in the thyroid gland caused a decrease in T3 content in 73 % of animals against the background of normal T4 and elevated FT4 levels, in 27 % of females the T3 level increased. In males, in 73 % of the observations, the T3 level was increased against the background of high T4 and FT4 values and unchanged TSH levels. In the skin and LLC samples of the mice of the main group, an increase in T3 levels was noted. Conclusion. The growth of LLC against the background of hyperthyroidism is a process with multifactorial effects. High levels of T3 in blood serum and skin stimulated the proliferation of tumor cells, which led to the formation of subcutaneous tumors of a larger volume in the mice of the main group. Sex differences in the GGT response indicate different mechanisms that implement pathological processes.
- 15 August 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (3) , 38-53
Open AccessFeatures of the functioning of the hypothalamic-pituitary-thyroid axis in mice with Lewis carcinoma on the background of induced hyperthyroidism
Thyroid hormones (TH) influence the processes of cell proliferation and differentiation, but their role in the processes of carcinogenesis is contradictory. The purpose of the study. To study the effect of induced hyperthyroidism in mice of both sexes with intertwined Lewis carcinoma (LLC) on the activity of the hypothalamic-pituitary-thyroid axis (GGT). Materials and methods. The experimental model was mixed-sex mice of the C57BL/6 line with subcutaneously transplanted LLC on the background of induced hyperthyroidism (main group). Two control groups were used: control group I – mice with sodium liothyronine- induced hyperthyroidism and control group II – mice with subcutaneously transplanted LLC. On the 25th day after tumor transplantation, the level of thyrotropin- releasing hormone (TRH), thyroid- stimulating hormone (TSH), triiodothyronine (T3), total and free thyroxine (T4, FT4) was determined in the homogenates of GGT organs and in blood serum. Results. In female mice, hyperthyroidism caused an increase in the level of TRH in the hypothalamus and a decrease in TSH in the pituitary gland; in males, a decrease in TRH only in the hypothalamus. In control group II, euthyroid disorder syndrome developed: In mice of both sexes, serum levels of T4 and FT4 were found to decrease against the background of unchanged T3 levels and an increase in TSH content only in females. In the females of the main group, an increase in the level of TSH in the thyroid gland caused a decrease in T3 content in 73 % of animals against the background of normal T4 and elevated FT4 levels, in 27 % of females the T3 level increased. In males, in 73 % of the observations, the T3 level was increased against the background of high T4 and FT4 values and unchanged TSH levels. In the skin and LLC samples of the mice of the main group, an increase in T3 levels was noted. Conclusion. The growth of LLC against the background of hyperthyroidism is a process with multifactorial effects. High levels of T3 in blood serum and skin stimulated the proliferation of tumor cells, which led to the formation of subcutaneous tumors of a larger volume in the mice of the main group. Sex differences in the GGT response indicate different mechanisms that implement pathological processes.
- Open Access
- 28 May 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (2) , 25-34
Features of anorectal function after radiation therapy in patients with rectal cancer
Purpose of the study. To study the function of the sphincter in patients with rectal cancer after chemoradiotherapy using the method of high-resolution anorectal manometry.Materials and methods. The study included 30 patients with cancer of the middle and lower ampullary rectum, who underwent combined treatment at the National Medical Research Center of Oncology. The patients underwent a course of neoadjuvant gamma radiation therapy using capecitabine. High-resolution anorectal manometry was performed before the start of treatment and 2 months after completion of chemoradiotherapy to study the functional parameters of the sphincter apparatus. The severity of anorectal dysfunction was assessed using the Wexner anal incontinence scale.Results. According to high-resolution anorectal manometry, the average pressure of the anal canal at rest decreased by 1.4 times (p < 0.05), and the average absolute compression pressure with voluntary contraction decreased by 1.2 times (p = 0.0012) after neoadjuvant chemoradiotherapy. A comparative assessment of the maximum absolute compression pressure at this stage of treatment did not allow us to trace a significant difference between its value before the start of radiation therapy and 2 months after its completion (p > 0.05). An increase in threshold sensitivity volumes was noted in 23 patients (p = 0.16). The use of the Wexner scale didn’t show a statistically significant change in the median scores according to the results of patient surveys following the completion of treatment (5.2 vs. 5.5 points, p > 0.05).Conclusions. Radiation therapy has an effect on anorectal function, which may contribute to the occurrence of low anterior resection syndrome after surgical treatment. For this reason, it is now necessary to carefully consider the risks of developing anorectal dysfunction. Equally important is the use of methods for the prevention of low anterior resection syndrome for patients who have received combined treatment for rectal cancer.
- 28 May 2024
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 5 (2) , 25-34
Open AccessFeatures of anorectal function after radiation therapy in patients with rectal cancer
Purpose of the study. To study the function of the sphincter in patients with rectal cancer after chemoradiotherapy using the method of high-resolution anorectal manometry.Materials and methods. The study included 30 patients with cancer of the middle and lower ampullary rectum, who underwent combined treatment at the National Medical Research Center of Oncology. The patients underwent a course of neoadjuvant gamma radiation therapy using capecitabine. High-resolution anorectal manometry was performed before the start of treatment and 2 months after completion of chemoradiotherapy to study the functional parameters of the sphincter apparatus. The severity of anorectal dysfunction was assessed using the Wexner anal incontinence scale.Results. According to high-resolution anorectal manometry, the average pressure of the anal canal at rest decreased by 1.4 times (p < 0.05), and the average absolute compression pressure with voluntary contraction decreased by 1.2 times (p = 0.0012) after neoadjuvant chemoradiotherapy. A comparative assessment of the maximum absolute compression pressure at this stage of treatment did not allow us to trace a significant difference between its value before the start of radiation therapy and 2 months after its completion (p > 0.05). An increase in threshold sensitivity volumes was noted in 23 patients (p = 0.16). The use of the Wexner scale didn’t show a statistically significant change in the median scores according to the results of patient surveys following the completion of treatment (5.2 vs. 5.5 points, p > 0.05).Conclusions. Radiation therapy has an effect on anorectal function, which may contribute to the occurrence of low anterior resection syndrome after surgical treatment. For this reason, it is now necessary to carefully consider the risks of developing anorectal dysfunction. Equally important is the use of methods for the prevention of low anterior resection syndrome for patients who have received combined treatment for rectal cancer.